The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Eligibility
Participation Requirements
Sex: All
Maximum Age: 18
Healthy Volunteers: f
View:
• Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
• Written informed consent from the patient and/or the parent/legal guardian
Locations
Other Locations
Italy
Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova]
RECRUITING
Padua
Contact Information
Primary
Gianni Bisogno, MD
gianni.bisogno@unipd.it
0039 0498211481
Backup
Martina Bonel, CRC
martina.bonel@unipd.it
0039 04908211481
Time Frame
Start Date: 2025-01-25
Estimated Completion Date: 2049-06-06
Participants
Target number of participants: 6250
Related Therapeutic Areas
Sponsors
Collaborators: University Hospital, Paris, Hellenic Oncology Research Group, University Medical Centre Ljubljana, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Institute for Oncology and Radiology Serbia, Belgrade, Gdansk Medical University (Poland), Centre Hospitalier Universitaire de La Réunion, FRANCE, Centro Hospitalar do Porto, University of Skopje, Klinikum Dortmund, University Hospital Bratislava, University of Bilbao, University Children's Hospital Tuebingen, Bucharest Emergency Hospital, Children's Hospital Zagreb, Kaplan Medical Center, Rehovot, Israel, Göteborg University, St. Anna Children's Hospital, Vienna, Vilnius University hospital Santaros klinikos, Vilnius, Lithuania
Leads: Azienda Ospedaliera di Padova